| Wearable sensors in Huntington disease: a pilot study KL Andrzejewski, AV Dowling, D Stamler, TJ Felong, DA Harris, C Wong, ... Journal of Huntington's disease 5 (2), 199-206, 2016 | 68 | 2016 |
| Telehealth management of Parkinson’s disease using wearable sensors: an exploratory study DA Heldman, DA Harris, T Felong, KL Andrzejewski, ER Dorsey, ... Digital biomarkers 1 (1), 43-51, 2017 | 60 | 2017 |
| Estrogen decreases expression of chemokine receptors, and suppresses chemokine bioactivity in murine monocytes K Janis, J Hoeltke, M Nazareth, P Fanti, K Poppenberg, SM Aronica American journal of reproductive immunology 51 (1), 22-31, 2004 | 60 | 2004 |
| Feasibility, reliability, and value of remote video-based trial visits in Parkinson’s disease CG Tarolli, K Andrzejewski, GA Zimmerman, M Bull, S Goldenthal, ... Journal of Parkinson's disease 10 (4), 1779-1786, 2020 | 42 | 2020 |
| Virtual visits for Parkinson disease: a multicenter noncontrolled cohort RE Korn, AW Shukla, M Katz, HT Keenan, S Goldenthal, P Auinger, ... Neurology: Clinical Practice 7 (4), 283-295, 2017 | 42 | 2017 |
| Lack of D2 receptor mediated regulation of dopamine synthesis in A11 diencephalospinal neurons in male and female mice SS Pappas, B Behrouz, KL Janis, JL Goudreau, KJ Lookingland Brain research 1214, 1-10, 2008 | 30 | 2008 |
| Cannabinoids in the treatment of movement disorders: A systematic review of case series and clinical trials K Andrzejewski, R Barbano, J Mink Basal Ganglia 6 (3), 173-181, 2016 | 28 | 2016 |
| Targeting kinases in Parkinson's disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium T Guttuso Jr, KL Andrzejewski, DG Lichter, JK Andersen Journal of the Neurological Sciences 402, 121-130, 2019 | 25 | 2019 |
| Characterization of endocannabinoid-metabolizing enzymes in human peripheral blood mononuclear cells under inflammatory conditions BN Szafran, JH Lee, A Borazjani, P Morrison, G Zimmerman, ... Molecules 23 (12), 3167, 2018 | 25 | 2018 |
| Estrogen decreases chemokine levels in murine mammary tissue: implications for the regulatory role of MIP-1 alpha and MCP-1/JE in mammary tumor formation P Fanti, M Nazareth, R Bucelli, M Mineo, K Gibbs, M Kumin, K Grzybek, ... Endocrine 22, 161-167, 2003 | 25 | 2003 |
| Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial EF Stimming, DO Claassen, E Kayson, J Goldstein, R Mehanna, H Zhang, ... The Lancet Neurology 22 (6), 494-504, 2023 | 22 | 2023 |
| Liquid chromatographic–electrospray mass spectrometric determination of 1-methyl-4-phenylpyridine (MPP+) in discrete regions of murine brain A Lehner, M Johnson, T Simkins, K Janis, K Lookingland, J Goudreau, ... Toxicology Mechanisms and Methods 21 (3), 171-182, 2011 | 18 | 2011 |
| Effects of sildenafil on nigrostriatal dopamine neurons in a murine model of Parkinson's disease KL Janis, RT Brennan, RE Drolet, B Behrouz, SK Kaufman, ... Journal of Alzheimer's Disease 15 (1), 97-107, 2008 | 7 | 2008 |
| Comparison of the D2 receptor regulation and neurotoxicant susceptibility of nigrostriatal dopamine neurons in wild-type and CB1/CB2 receptor knockout mice TJ Simkins, KL Janis, AK McClure, B Behrouz, SS Pappas, A Lehner, ... Journal of Neuroimmune Pharmacology 7, 533-538, 2012 | 6 | 2012 |
| Virtual research visits in individuals with Parkinson disease enrolled in a clinical trial: REACT-PD Study Interim Analysis (P4. 005) C Tarolli, K Andrzejewski, M Bull, S Goldenthal, M O’Brien, T Simuni, ... Neurology 88 (16 Supplement), 2017 | 5 | 2017 |
| Virtual research visits in individuals with Parkinson disease enrolled in a clinical trial: REACT-PD Study (P3. 038) C Tarolli, K Andrzejewski, G Zimmerman, M Bull, S Goldenthal, M O’Brien, ... Neurology 90 (15 Supplement), 2018 | 3 | 2018 |
| Utilizing remote blood pressure monitoring in a Phase III clinical drug trial for Parkinson's disease JL Adams, RA Biemiller, KL Andrzejewski, S Sharma, RL Rockhill, ... MOVEMENT DISORDERS 31, S687-S687, 2016 | 3 | 2016 |
| Alterations in vestibular function in individuals with cervical dystonia and the effects of botulinum toxin treatment KL Andrzejewski, S Ma, A Owens, MT Bull, KM Biglan, S Kanchana, ... Basal Ganglia 13, 1-6, 2018 | 2 | 2018 |
| Virtual research visits in individuals with Parkinson disease enrolled in STEADY-PD III: The REACT-PD study KL Andrzejewski, MT Bull, S Goldenthal, M O'Brien, T Simuni, ER Dorsey, ... MOVEMENT DISORDERS 31 (9), E11-E11, 2016 | 1 | 2016 |
| Hunting for an Ovarian Teratoma in Anti-NMDA Receptor Encephalitis (P06. 010) F Ashraf, K Janis, B Walter Neurology 78 (1 Supplement), P06. 010-P06. 010, 2012 | 1 | 2012 |
